AbbVie Acquires Celsius Therapeutics
Celsius’ CEL383 is a potential first-in-class anti-Triggering Receptor Expressed on Myeloid Cells 1 (TREM1) antibody for the treatment of inflammatory bowel disease (IBD) NORTH CHICAGO, Ill., June 27, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) announced today the acquisition of Celsius Ther
Canadian Journalism Foundation Announces Four New Board Members
TORONTO, June 27, 2024 /CNW/ – The Canadian Journalism Foundation (CJF) is pleased to announce four new members to its Board of Directors. They are: Toronto Star Queen’s Park Bureau Chief Robert Benzie; BNN Bloomberg anchor and reporter Amber Kanwar; Erin Millar, CEO & Co-Founder,
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
SEATTLE, June 27, 2024 /PRNewswire/ — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced today the completion of a $20M financing from new
Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials
NEW YORK, June 27, 2024 /PRNewswire/ — Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has unveiled their all-encompassing contract research organization (CRO) and technology solution customized for the execution of m
50/50 Women on Boards™ Unveils Second Annual “50 Women to Watch for Boards” List: Bridging Board-Ready Candidates with Public Companies and Recruiters from All Sectors
LOS ANGELES, June 27, 2024 /PRNewswire/ — 50/50 Women on Boards™ (50/50WOB), the leading global nonprofit education and advocacy campaign driving the movement toward gender balance and diversity on corporate boards, announced its highly anticipated 2024 list of 50 Women to Watch for Boards
Content Credits Revolutionizes Online Content Accessibility for Publishers, Businesses and Consumers
New micropayments platform enables publishers to convert 97% bounce rates into revenue CINCINNATI and COVINGTON, Ky., June 27, 2024 /PRNewswire/ — Content Credits, a new micropayments platform, is proud to announce its commitment to bringing quality content to people of all income levels and
KAZIA ANNOUNCES UPCOMING DIPG DATA PRESENTATIONS AT ISPNO AND PUBLICATION IN EUROPEAN JOURNAL OF CANCER
SYDNEY, June 27, 2024 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce the presentation of new data from its lead program, paxalisib, at the upcoming 21st International Symposium on Pediatric Neuro-Oncology (ISPN
Bladex Acts as Joint Lead Arranger and Bookrunner for Interceramic US$665mm Syndicated Loan Facility
PANAMA CITY, June 27, 2024 /PRNewswire/ — Banco Latinoamericano de Comercio Exterior (“Bladex”, or “the Bank”, NYSE: BLX) announced today the successful structuring of a syndicated loan for US$665 million, consisting of a US$600 million tranche for 12 months and a US$65
Scalefocus Wins Trio of Prestigious Gold Globee® Awards for Innovation and Excellence
SOFIA, Bulgaria, June 27, 2024 /PRNewswire/ — Scalefocus, the trusted provider of tailored software solutions and services, has won three prestigious Gold Globee® Awards for its outstanding contributions to technology and innovation. These accolades highlight the company’s commitment to
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
CAMBRIDGE, Mass., June 27, 2024 /PRNewswire/ — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in the H.C. Wainwright 3
